Analysis of Secondary Metabolite Synthesis Potential of <i>Streptomyces fradiae</i> sf106 Based on the Whole Genome and Non-Target Metabolomics and Exploration of the Biosynthesis of Tylosin

<i>Streptomyces fradiae</i> sf106 is a type of actinomycete that can produce abundant secondary metabolites, making it a natural cell factory for drug synthesis. In order to comprehensively understand the genomic profile of <i>Streptomyces fradiae</i> sf106 and its potential...

Full description

Bibliographic Details
Main Authors: Chenbo Jia, Xian Ma, Yuting Jiang, Shanshan Cheng, Sijun Yue, Jianyu Su
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Fermentation
Subjects:
Online Access:https://www.mdpi.com/2311-5637/9/10/866